Cargando…
Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity
Acute respiratory infections are a leading cause of death worldwide. Clinical data is conflicted regarding whether statins improve outcomes for pneumonia. Potential confounding factors including specific etiology of pneumonia as well as obesity could potentially mask protective benefit. Obesity is a...
Autores principales: | Karlsson, Erik A., Schultz-Cherry, Stacey, Rosch, Jason W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819214/ https://www.ncbi.nlm.nih.gov/pubmed/29497602 http://dx.doi.org/10.3389/fcimb.2018.00041 |
Ejemplares similares
-
Increased Zinc Availability Enhances Initial Aggregation and Biofilm Formation of Streptococcus pneumoniae
por: Brown, Lindsey R., et al.
Publicado: (2017) -
Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Karlsson, Erik A., et al.
Publicado: (2016) -
Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection
por: Xu, Qian, et al.
Publicado: (2023) -
The roles of transition metals in the physiology and pathogenesis of Streptococcus pneumoniae
por: Honsa, Erin S., et al.
Publicado: (2013) -
Protochlamydia
naegleriophila as Etiologic Agent of Pneumonia
por: Casson, Nicola, et al.
Publicado: (2008)